Clinical trial
Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung…
NCT00087048 · Case Comprehensive Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00087048 |
|---|---|
| Title | Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer |
| Official title | The Use Of Weekly Topotecan As Second Line Therapy In Small Cell Lung Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | topotecan hydrochloride |
| Enrollment | 1 |
| Start date | Apr 1, 2004 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Jul 12, 2004 |
| Last update posted | Mar 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: